News

Corbus Pharmaceuticals Announces Presentation of Three Abstracts and New Lenabasum Data at 2018 ACR Annual Meeting

Corbus Pharmaceuticals Holdings, Inc., a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization of novel therapeutics to treat rare, chronic and serious inflammatory and fibrotic diseases, announced today that its abstracts have been selected for presentations at the American College of Rheumatology (“ACR”) 2018 Annual Meeting being held October 19-24, 2018 in Chicago, Illinois. Read more >>
Read more...

Wasabi Secures $68 Million Funding Round, Bypasses Traditional VC Financing

Wasabi, the hot cloud storage company, today announces the closing of a Series B financing round totaling $68 million. Wasabi refrained from conventional venture capital, preferring instead to raise money from industry veterans and family offices. The investment is a testament to Wasabi’s progress in becoming a leading vendor of cheap, fast, and secure cloud storage. In just over a year, Wasabi has acquired more than 3,000 customers across a wide range of industries. Read more >>
Read more...

Boston Harbor Angels Brings Equity Venture Partners as New Sponsor

Boston Harbor Angels, one of the top three elite angels groups in the US, is pleased to announce that Equity Venture Partners has joined as a new sponsor. About Equity Venture Partners Equity Venture Partners (www.equityvp.com) provides fee simple ownership in Class A & B commercial real estate investment opportunities nationwide to accredited investors with a focus on attaining the greatest risk-adjusted rate of return. We act as the General Partner on all EVP investments and unlike many other firms that sponsor...
Read more...